Major and durable response to second-line pembrolizumab-carboplatin-paclitaxel in an oral cavity cancer patient

  1. Cabezas-Camarero, S.
  2. Cabrera-Martin, M.N.
  3. Saiz-Pardo Sanz, M.
  4. Perez-Segura, P.
Journal:
Anti-Cancer Drugs

ISSN: 1473-5741 0959-4973

Year of publication: 2021

Volume: 32

Issue: 5

Pages: 580-584

Type: Article

DOI: 10.1097/CAD.0000000000001040 GOOGLE SCHOLAR

Sustainable development goals